Charles River Laboratories International saw the highest growth of 2.99% in patent filings and 0.32% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.99% and grants by 0.32%. GlobalData’s DataBook provides a comprehensive analysis of Charles River Laboratories International‘s patent filings and grants. Buy the databook here.
Charles River Laboratories International has been focused on protecting inventions in United States(US) with ten publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 89% filings and 100% grants. The United States(US), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Charles River Laboratories International is filings its patents. Among the top granted patent authorities, Charles River Laboratories International has 100% of its grants in United States(US).
Roche could be the strongest competitor for Charles River Laboratories International
Patents related to rare diseases and artificial intelligence lead Charles River Laboratories International's portfolio
Charles River Laboratories International has the highest number of patents in rare diseases followed by, artificial intelligence and industrial automation. For rare diseases, nearly 60% of patents were filed and 33% of patents were granted in Q2 2024.
Breast cancer related patents lead Charles River Laboratories International portfolio followed by prostate cancer, and non-small cell lung cancer
Charles River Laboratories International has highest number of patents in breast cancer followed by prostate cancer, non-small cell lung cancer, systemic sclerosis (scleroderma), and colon cancer.
For comprehensive analysis of Charles River Laboratories International's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.